机译:新型多巴胺D3受体拮抗剂/部分激动剂CAB 2-015和BAK4-54抑制大鼠羟考酮和羟考酮的行为
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Molecular Targets and Medications Discovery Branch National Institute on Drug Abuse Intramural;
Dopamine D3 receptor antagonist; CAB2-015; BAK4-54; Prescription opioid; Oxycodone; Self-administration;
机译:新型多巴胺D3受体拮抗剂/部分激动剂CAB 2-015和BAK4-54抑制大鼠羟考酮和羟考酮的行为
机译:选择性多巴胺D3受体拮抗剂SB-277011A和NGB 2904以及推定的部分D3受体激动剂BP-897会减轻大鼠甲基苯丙胺增强的脑刺激。
机译:F15063,一种多巴胺D2 sub> / D3 sub>拮抗剂,5-HT1A sub>激动剂和D4 sub>部分激动剂的潜在抗精神病药:(IV)脑D2样受体的持续时间和类抗精神病药活性与血浆中血浆浓度的关系
机译:L- StepHolidine,天然存在的多巴胺D1受体激动剂和D2受体拮抗剂,衰减甲基苯丙胺自我管理
机译:大鼠多巴胺D2和D3受体激动剂和拮抗剂的行为药理学。
机译:两名新型多巴胺D3受体选择性局部激动剂OS-3-106和WW-III-55减少可卡因自我管理和D3受体介导的行为
机译:选择性多巴胺D3受体拮抗剂SB-277011A和NGB 2904和推定的部分D3受体激动剂BP-897在大鼠中衰减甲基苯丙胺增强的脑刺激奖励